Prosecution Insights
Prosecution Insights
120 pending office actions • 61 clients • 113 examiners • 60 art units • 0 of 120 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 59 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 59 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (1%) |
| §101 + other | 10 (8%) |
| §103 only | 21 (18%) |
| §102 only | 4 (3%) |
| §112 only | 11 (9%) |
| Double-patenting only | 5 (4%) |
| Double-patenting + other | 10 (8%) |
| Multi-statute (no §101) | 58 (48%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIKNIS, ZACHARY J | 2 | 68.3% | +32.5% |
| SVEIVEN, MICHAEL CAMERON | 2 | 36.4% | +56.5% |
| MATALKAH, FATIMAH KHALAF | 2 | 55.3% | +28.5% |
| GUSTILO, ESTELLA M | 2 | 53.2% | +36.8% |
| STEINKE, SEAN JAMES | 2 | 12.5% | +42.9% |
| SINGH, ANOOP KUMAR | 2 | 42.7% | +67.3% |
| VIVLEMORE, TRACY ANN | 2 | 73.0% | +6.7% |
| PREMRAJ, CATHERINE C | 1 | 56.4% | +48.4% |
| LI, WENHAN | 1 | — | — |
| LIU, TRACY | 1 | 54.5% | +27.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17769524 | METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN | KIM, TAEYOON | 147d overdue |
| 18783166 | TRANSMEMBRANE SENSOR TO EVALUATE NEUROMUSCULAR FUNCTION | ROBERTS, ANNA L | 111d overdue |
| 17777011 | SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLES | SVEIVEN, MICHAEL CAMERON | 80d overdue |
| 17583549 | Composition for and Method of Improving Tissue Performance | REYNOLDS, FRED H | 72d overdue |
| 17584547 | CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATORY DOMAINS | SINGH, ANOOP KUMAR | 59d overdue |
| 17269968 | TREATMENT OF FLAVIVIRUS INFECTIONS IN HUMANS USING MUS MUSCULUS RESISTANT 2'-5' OLIGOADENYLATE SYNTHETASE 1B | DUNSTON, JENNIFER ANN | 53d overdue |
| 18622465 | CARBON NANOTUBE-BASED THERMAL INTERFACE MATERIALS AND METHODS OF MAKING AND USING THEREOF | ROJOHN III, CLAIRE E | 36d overdue |
| 17557920 | ZERO-VALENT METAL AND BLACK CARBON FRAMEWORK AND METHOD OF USING SAME | MAYES, MELVIN C | 28d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17777011 | SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLES | SVEIVEN, MICHAEL CAMERON | 80d overdue |
| 17584547 | CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATORY DOMAINS | SINGH, ANOOP KUMAR | 59d overdue |
| 18546302 | CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES | GUSTILO, ESTELLA M | 24d overdue |
| 18564498 | BIOENGINEERED DERMAL PAPILLA AND HAIR FOLLICLES AND RELATED PRODUCTS, METHODS AND APPLICATIONS | MATALKAH, FATIMAH KHALAF | 13d |
| 18179069 | ENTERAL CARBON MONOXIDE FOR THE PREVENTION AND TREATMENT OF OCULAR DISEASES | STEINKE, SEAN JAMES | 34d |
| 18178282 | PIG XENOTRANSPLANTS INTO HUMANS WITHOUT CHRONIC IMMUNOSUPPRESSION | SINGH, ANOOP KUMAR | 63d |
| 18990707 | METHODS TO IDENTIFY A PRESENCE OR ABSENCE OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS | PREMRAJ, CATHERINE C | — |
| 18905699 | SHAPEABLE SCAFFOLD MATERIAL AND USES THEREOF | LIU, TRACY | — |
| Art Unit | Apps |
|---|---|
| 1653 | 5 |
| 1654 | 5 |
| 1619 | 4 |
| 1638 | 4 |
| 1631 | 4 |
| 1671 | 4 |
| 1637 | 4 |
| 3791 | 3 |
| 1674 | 3 |
| 1678 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18990707 | METHODS TO IDENTIFY A PRESENCE OR ABSENCE OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS | Powell Mansfield, Inc. | PREMRAJ, CATHERINE C | §101 | Non-Final OA | — | Pending | Dec 20, 2024 | |
| 18856787 | NANOPARTICLES AND NANOPARTICLE-RELEASING VAGINAL RINGS | Yale University | LI, WENHAN | §102§103 | Non-Final OA | — | Pending | Oct 14, 2024 | |
| 18905699 | SHAPEABLE SCAFFOLD MATERIAL AND USES THEREOF | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) | LIU, TRACY | DP | Non-Final OA | — | Pending | Oct 03, 2024 | |
| 18835557 | COMPOSITIONS | Imperial College Innovations Ltd. | WRIGHT, ERIC BRANDON | §102 | Non-Final OA | — | Pending | Aug 02, 2024 | |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | PIPIC, ALMA | 1617 | §103§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18783166 | TRANSMEMBRANE SENSOR TO EVALUATE NEUROMUSCULAR FUNCTION | Powell Mansfield, Inc. | ROBERTS, ANNA L | 3791 | §103§112 | Final Rejection | 111d overdue | Pending | Jul 24, 2024 |
| 18772004 | MUNITIONS AND ORDNANCE REMEDIATION BLANKET (MORB) AND METHODS OF USING SAME | MuniRem Environmental, LLC | HAYES, BRET C | 3641 | §112DP | Final Rejection | — | Pending | Jul 12, 2024 |
| 18674209 | POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF | Yale University | COHEN, MICHAEL P | 1612 | §102Other | Non-Final OA | 16d | Pending | May 24, 2024 |
| 18661820 | BACTERIOPHAGE-DERIVED NANOPORE SENSORS | Oxford Nanopore Technologies PLC | BALL, JOHN C | 1795 | §103 | Final Rejection | 46d overdue | Pending | May 13, 2024 |
| 18653590 | OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | The University of Hong Kong | IANNUZO, NATALIE NMN | 1653 | §103§112 | Non-Final OA | — | Pending | May 02, 2024 |
| 18653312 | COMPOSITIONS AND METHODS FOR TARGETING CD99-EXPRESSING CANCERS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | XIE, XIAOZHEN | 1674 | §112 | Non-Final OA | 26d overdue | Pending | May 02, 2024 |
| 18652429 | TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF | Sanford Burnham Prebys Medical Discovery Institute | HA, JULIE | 1654 | DP | Final Rejection | 14d | Pending | May 01, 2024 |
| 18704758 | DESIGNER EXTRACELLULAR VESICLES FOR TARGETED DELIVERY TO SCHWANN CELLS | Ohio State Innovation Foundation | OGUNBIYI, OLUWATOSIN A | 1645 | §102§103§112 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18703995 | METHODS OF TREATING CANCER | Fusion Pharmaceuticals Inc. | MOSHER, ERIC PARKER | §103§112DP | Non-Final OA | — | Pending | Apr 23, 2024 | |
| 18701567 | DELIVERY OF THERAPEUTIC RECOMBINANT URICASE USING NANOPARTICLES | Georgia Tech Research Corporation | BOWERS, ERIN M | 1653 | §103DP | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18635508 | TREATMENT OF CANCERS OR NEOPLASMS BY INHIBITING KIF15 | UNIVERSITY OF KANSAS | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | §102§112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18622465 | CARBON NANOTUBE-BASED THERMAL INTERFACE MATERIALS AND METHODS OF MAKING AND USING THEREOF | Carbice Corporation | ROJOHN III, CLAIRE E | 3763 | §102§103 | Final Rejection | 36d overdue | Pending | Mar 29, 2024 |
| 18605474 | COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE | Ramot AT Tel-Aviv University Ltd. | NEAGU, IRINA | 1629 | §102§103§112Other | Non-Final OA | 4d overdue | Pending | Mar 14, 2024 |
| 18690140 | PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT | D&D Pharmatech Inc. | NIEBAUER, RONALD T | 1612 | §101§102§103§112DP | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18686711 | GLP-1R AGONISTS FOR USE IN A TREATMENT OF NEUROLOGIAL IMPAIRMENT ASSOCIATED WITH VIRAL INFECTION | Neuraly, Inc. | MIKNIS, ZACHARY J | DP | Non-Final OA | — | Pending | Feb 26, 2024 | |
| 18681561 | FIBRINOGEN COMPOSITIONS AND METHODS OF PREPARATION | Biotest AG | GOTFREDSON, GAREN | 1619 | §103 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18566491 | FIBROSIS BIOMARKERS FOR NON-ALCOHOLIC FATTY LIVER DISEASE | The University of Hong Kong | SVEIVEN, MICHAEL CAMERON | 1678 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18565831 | METHODS OF USING ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T CELLS | Regents Of The University Of Minnesota | HAM, JIEUN | §103§112DP | Non-Final OA | — | Pending | Nov 30, 2023 | |
| 18521615 | POLYMER COATED IRON OXIDE NANORODS AND METHODS OF MAKING AND USE THEREOF | 5M Biomed, LLC | BAEK, JONGHWAN NMN | 1618 | DP | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18564498 | BIOENGINEERED DERMAL PAPILLA AND HAIR FOLLICLES AND RELATED PRODUCTS, METHODS AND APPLICATIONS | The University of Hong Kong | MATALKAH, FATIMAH KHALAF | 1638 | §103§112 | Non-Final OA | 13d | Pending | Nov 27, 2023 |
| 18506988 | A-FABP NEUTRALIZING MONOCLONAL ANTIBODY AND PREPARATION METHOD AND USE THEREOF | Shenzhen Institute Of Advanced Technology, Chinese Academy Of Sciences | MCCOLLUM, ANDREA K | 1674 | §103§112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18558943 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | Yale University | SPANGLER, JOSEPH RANKIN | 1656 | §103§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18500774 | ENGINEERED EXOSOMES TO DETECT AND DEPLETE PRO-TUMORIGENIC MACROPHAGES | Augusta University Research Institute, Inc. | NICOL, ALEXANDER W | 1634 | §103§112 | Non-Final OA | 13d | Pending | Nov 02, 2023 |
| 18383131 | Filter and Frame Apparatus and Method of Use | Delcath Systems, Inc. | KURTZ, BENJAMIN M | 1779 | DP | Final Rejection | — | Pending | Oct 24, 2023 |
| 18490443 | USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING | The Regents of the University of California | PHILIPOSE, HANNAH SARAH | 1631 | §103§112 | Non-Final OA | 2d overdue | Pending | Oct 19, 2023 |
| 18554144 | EFFECT OF GHRH ANTAGONISTS IN DIABETES AND OBESITY | The United States Government AS Represented By The Dept. Of Veterans Affairs | BUCCINI, MICHELLE CALLAHAN | 1675 | §102§103§112DP | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18473841 | MICRONEEDLE DEVICE FOR CONTROL OF THYROID HORMONE LEVELS | Equilibrate Therapeutics, LLC | PONTON, JAMES D | 3783 | §102§103§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18464817 | Dental Care Products Comprising Stannous Flouride | Credentis AG | JAUHARI, SACHI | 1654 | §103 | Final Rejection | 26d | Pending | Sep 11, 2023 |
| 18549950 | CHIPS AND METHODS | Imperial College Innovations Ltd. | KIDWELL, KAITLYN ELIZABETH | 2877 | §103 | Non-Final OA | 85d overdue | Pending | Sep 11, 2023 |
| 18548206 | R-T-B MAGNET AND PREPARATION METHOD THEREFOR | Fujian Golden Dragon Rare-Earth Co., Ltd. | MCGUTHRY BANKS, TIMA MICHELE | 1733 | §103§112Other | Non-Final OA | — | Pending | Aug 28, 2023 |
| 18547976 | EXTRACELLULAR VESICLE-BASED NANOCARRIERS | Ohio State Innovation Foundation | BLUMEL, BENJAMIN P | 1671 | §103 | Non-Final OA | — | Pending | Aug 25, 2023 |
| 18546720 | CANNABIDIOL FOR TREATING NEURODEGENERATIVE DISEASES | Augusta University Research Institute, Inc. | JAVANMARD, SAHAR | 1622 | §102§112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18546302 | CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES | H. Lee Moffitt Cancer Center and Research Institute, Inc. | GUSTILO, ESTELLA M | 1646 | §102§103§112 | Non-Final OA | 24d overdue | Pending | Aug 14, 2023 |
| 18364503 | ENGINEERED NATURAL LIGAND-BASED CAR: DIRECTED EVOLUTION OF THE STRESS-RECEPTOR NKP30 | The Trustees of Dartmouth College | FAUST, AMBER KATHLEEN | 1643 | §102§103§112 | Non-Final OA | — | Pending | Aug 03, 2023 |
| 18263381 | CHEMOTHERAPEUTIC BIOADHESIVE PARTICLES WITH IMMUNOSTIMULATORY MOLECULES FOR CANCER TREATMENT | Yale University | DAVIS, BRIAN J | 1614 | §102§112 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18262287 | BI-SPECIFIC CAR T CCELLS FOR B CELL MALIGNANCIES | H. Lee Moffitt Cancer Center and Research Institute, Inc. | METCALF, MATTHEW CURRAN | 1647 | §103Other | Non-Final OA | 28d | Pending | Jul 20, 2023 |
| 18352040 | COMPOSITIONS AND METHODS TARGETING S100A10 FOR THE TREATMENT AND DIAGNOSIS OF LIVER CANCER | The University of Hong Kong | CASH, KAILEY ELIZABETH | 1683 | §101§102§103§112 | Non-Final OA | 22d overdue | Pending | Jul 13, 2023 |
| 18350402 | COMPOSITIONS OF CASPASE INHIBITORS AND METHODS OF USE THEREOF | Centre For Virology, Vaccinology And Therapeutics Limited | MIKNIS, ZACHARY J | 1658 | §102§112 | Non-Final OA | — | Pending | Jul 11, 2023 |
| 18347151 | CRYOGEL 3D SCAFFOLDS AND METHODS FOR PRODUCING THEREOF | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) | MOLOYE, TITILAYO | 1632 | §102§103§112DP | Non-Final OA | — | Pending | Jul 05, 2023 |
| 18346483 | SYSTEMS AND REAGENTS FOR DETECTION OF FREE MONOCLONAL IMMUNOGLOBULIN LIGHT CHAINS IN BIOLOGICAL SAMPLES | Augusta University Research Institute, Inc. | MARCSISIN, ELLEN JEAN | 1677 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 03, 2023 |
| 18345284 | SUPER-HIGH-PERMEANCE THIN-FILM COMPOSITE NANOFILTRATION MEMBRANE INCORPORATING SILK NANOFIBER INTERLAYER | The University of Hong Kong | HUANG, RYAN | 1777 | §102 | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18345934 | STEM CELL COMPOSITIONS FOR CULTURING CORONAVIRUSES AND METHODS OF MAKING AND USING THEREOF | Centre For Translational Stem Cell Biology Limited | ALAM, DANYAL HASSAN | 1672 | §101§103§112 | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18258870 | A DEVICE AND A METHOD | Imperial College Innovations Limited | WORRELL, KEVIN | 1789 | §102§103§112 | Final Rejection | — | Pending | Jun 22, 2023 |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | VERSITECH LIMITED | LI, BAO Q | 1671 | §103 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18335922 | COMPOSITIONS CONTAINING AMINO ACIDS AS AN ADMIXTURE FOR CEMENT-BASED MATERIALS | The University of Maine System Board of Trustees | GREEN, ANTHONY J | 1731 | §102§103§112 | Non-Final OA | 25d overdue | Pending | Jun 15, 2023 |
| 18254669 | LENTIVIRAL VECTOR TECHNOLOGY FOR INNER EAR GENE THERAPY | Medizinische Hochschule Hannover | YU, DELPHINUS DOU YI | 1636 | §103 | Final Rejection | — | Pending | May 26, 2023 |
| 18254468 | Superior Neutralization of SARS-CoV-2 by Deglycosylated Human Angiotensin Converting Enzyme 2 (ACE2) | IMBA - Institut für Molekulare Biotechnologie GmbH | HOWARD, ZACHARY C | 1674 | §102§103§112 | Non-Final OA | — | Pending | May 25, 2023 |
| 18036825 | METHODS AND COMPOSITIONS FOR CANCER THERAPY | Ohio State Innovation Foundation | FAY, ZOHREH ALEMZADEH | 1617 | §103§112 | Non-Final OA | — | Pending | May 12, 2023 |
| 18251078 | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY LUNG DISEASES | Arizona Board of Regents | BEANE, RANDALL L | 1654 | §102§112 | Non-Final OA | 55d | Pending | Apr 28, 2023 |
| 18249926 | COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND/OR COMPOUNDS AND METHODS OF USE THEREOF | The University of Hong Kong | KATAKAM, SUDHAKAR | 1658 | §112DP | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18249648 | ACCELERATING TOOTH REMINERALISATION AND BONE REGENERATION WITH SELF-ASSEMBLING PEPTIDES AND AMORPHOUS CALCIUM PHOSHATE | Credentis AG | HELLMAN, KRISTINA M | 1654 | §102§112 | Non-Final OA | 84d | Pending | Apr 19, 2023 |
| 18030801 | METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS | The Trustees of Dartmouth College | MYERS, CARLA J | 1682 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18247210 | COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE | Decima Diagnostics, LLC | PRIEST, AARON A | 1681 | §101§103§112 | Non-Final OA | — | Pending | Mar 29, 2023 |
| 18245115 | COMPOSITIONS AND METHODS OF USE THEREOF FOR PREVENTION AND TREATMENT OF INFLUENZA INFECTIONS | The United States Of America, AS Represented By The Secretary Of Agriculture | HILL, MYRON G | 1671 | §112 | Final Rejection | — | Pending | Mar 13, 2023 |
| 18179069 | ENTERAL CARBON MONOXIDE FOR THE PREVENTION AND TREATMENT OF OCULAR DISEASES | Hillhurst Biopharmaceuticals, Inc. | STEINKE, SEAN JAMES | 1619 | §102§103Other | Final Rejection | 34d | Pending | Mar 06, 2023 |
| 18178282 | PIG XENOTRANSPLANTS INTO HUMANS WITHOUT CHRONIC IMMUNOSUPPRESSION | Nugift Medical LLC | SINGH, ANOOP KUMAR | 1632 | §112 | Non-Final OA | 63d | Pending | Mar 03, 2023 |
| 18170296 | COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY | The University of Hong Kong | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103§112 | Non-Final OA | — | Pending | Feb 16, 2023 |
| 18169695 | HEMOSTATIC NANOPARTICLES FOR THE TREATMENT OF NON-COMPRESSIBLE HEMORRHAGE AND INTERNAL BLEEDING | The General Hospital Corporation | STEVENS, MARK V | 1613 | §101§102§103§112 | Non-Final OA | 14d | Pending | Feb 15, 2023 |
| 18041542 | CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATING AUTOIMMUNITY | Regents Of The University Of Minnesota | BELYAVSKYI, MICHAIL A | 1644 | §102§103Other | Non-Final OA | — | Pending | Feb 13, 2023 |
| 18041504 | COMPOSITIONS AND METHODS FOR ENGINEERING AND SELECTION OF CAR T CELLS WITH DESIRED PHENOTYPES | Yale University | GROOMS, TIFFANY NICOLE | 1637 | §103 | Non-Final OA | — | Pending | Feb 13, 2023 |
| 18012468 | A MECHANOMYOGRAPHY APPARATUS AND ASSOCIATED METHODS | Imperial College Innovations Limited | CERIONI, DANIEL LEE | 3791 | §103§112 | Final Rejection | 1d overdue | Pending | Dec 22, 2022 |
| 18063604 | COMPOSITIONS AND METHODS FOR IMPROVED MESENCHYMAL STEM CELL THERAPY | The Chinese University of Hong Kong | WHITE, DAWANNA SHAR-DAY | 1627 | §103 | Final Rejection | 18d overdue | Pending | Dec 08, 2022 |
| 18000425 | SSTR-2 Binding Chimeric Antigen Receptors | UNIVERSITA' DEGLI STUDI DI BARI ALDO MORO | DARPOLOR, JOSEPHINE KEBBEH | 1642 | §102§103 | Final Rejection | 9d | Pending | Dec 01, 2022 |
| 18000312 | Dual EGFR-MUC1 Chimeric Antigen Receptor T Cells | H. Lee Moffitt Cancer Center and Research Institute, Inc. | HOPKINS, SAMANTHA LAKE | 1641 | §102§103§112Other | Non-Final OA | 20d | Pending | Nov 30, 2022 |
| 18058169 | VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF | Centre For Virology, Vaccinology And Therapeutics Limited | KINSEY WHITE, NICOLE ERIN | 1672 | §102§103§112 | Non-Final OA | 23d overdue | Pending | Nov 22, 2022 |
| 17998975 | A METHOD AND DEVICE FOR OPTICAL QUANTIFICATION OF OXYGEN PARTIAL PRESSURE IN BIOLOGICAL TISSUES | Laboratory For Functional And Metabolic Imaging Swiss Federal Instiute Of Technology (Epfl) | HEALY, NOAH MICHAEL | 3791 | §102§112 | Final Rejection | 33d | Pending | Nov 16, 2022 |
| 17998790 | CANNABIDIOL AS A THERAPEUTIC MODALITY FOR COVID-19 | Augusta University Research Institute, Inc. | RAMACHANDRAN, UMAMAHESWARI | 1627 | §103 | Final Rejection | 23d | Pending | Nov 14, 2022 |
| 18046619 | DIAGNOSIS AND TREATMENT OF CANCER | Rab Diagnostics AS | YAO, LEI | 1642 | §103 | Final Rejection | 23d | Pending | Oct 14, 2022 |
| 17996287 | IDENTIFICATION OF NSP1 GENE AS TARGET OF SARS-COV-2 REAL-TIME RT-PCR USING NANOPORE WHOLE GENOME SEQUENCING | The University of Hong Kong | WANG, RUIXUE | 1672 | §103§112 | Final Rejection | — | Pending | Oct 14, 2022 |
| 17930591 | COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF | VERSITECH LIMITED | HOLLAND, PAUL J | 1656 | §103 | Final Rejection | 23d | Pending | Sep 08, 2022 |
| 17905131 | TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED TUMOR REACTIVITY | H. Lee Moffitt Cancer Center and Research Institute, Inc. | ABUZEINEH, HANAN ISAM | 1633 | §103 | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17821411 | COMPOSITIONS AND METHODS FOR DETECTING SARS-CoV-2 | The University of Hong Kong | BARRERA, IMMACULADA | 1671 | §103§112 | Final Rejection | 4d overdue | Pending | Aug 22, 2022 |
| 17797503 | METHODS FOR DETECTING PRIMARY IMMUNODEFICIENCY | Immunosis Pty Ltd. | STUBBS, JOHN THOMAS | 1686 | §101§103§112 | Non-Final OA | — | Pending | Aug 04, 2022 |
| 17868214 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | Laboratory For Synthetic Chemistry And Chemical Biology Limited | KUMAR, SRILAKSHMI K | 1738 | §102 | Final Rejection | — | Pending | Jul 19, 2022 |
| 17850720 | COMPOSITIONS AND METHODS FOR OPTOCHEMICAL CONTROL OF MTOR SIGNALING AND MTOR-DEPENDENT AUTOPHAGY | The University of Hong Kong | NOTTINGHAM, KYLE GREGORY | 1621 | §103§112 | Final Rejection | — | Pending | Jun 27, 2022 |
| 17757475 | Systems and Methods for Producing Efficacious Regulatory T Cells | H. Lee Moffitt Cancer Center and Research Institute, Inc. | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103 | Non-Final OA | — | Pending | Jun 16, 2022 |
| 17782252 | ADOPTIVE CELL THERAPY WITH ZBTB20 SUPPRESSION | The Trustees of Dartmouth College | MATALKAH, FATIMAH KHALAF | 1638 | §112 | Final Rejection | — | Pending | Jun 03, 2022 |
| 17756138 | AKT INHIBITORS FOR ENHANCING CHIMERIC T CELL PERSISTENCE | H. Lee Moffitt Cancer Center and Research Institute, Inc. | VIVLEMORE, TRACY ANN | 1638 | §112 | Non-Final OA | 44d overdue | Pending | May 18, 2022 |
| 17777011 | SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLES | Arizona Board of Regents | SVEIVEN, MICHAEL CAMERON | 1678 | §103§112Other | Non-Final OA | 80d overdue | Pending | May 13, 2022 |
| 17735271 | COMPOSITIONS AND METHODS OF USING NMDAR INHIBITORS AND KINASE INHIBITORS TO TREAT LIVER CANCER | Centre For Oncology And Immunology Limited | MCANANY, JOHN D | 1625 | §102§103§112 | Final Rejection | 12d | Pending | May 03, 2022 |
| 17734826 | COMPOSITE FILAMENT FOR 3D PRINTING OF RESORBABLE BONE SCAFFOLDS | Arizona Board of Regents | BAHENA, CHRISTIE L. | 3774 | §103 | Non-Final OA | 28d | Pending | May 02, 2022 |
| 17729584 | SURGERY DEVICE WITH PATIENT-SPECIFIC FIBULA MALLEOLUS CAP | The University of Hong Kong | HU, ANN M | 3774 | §102§103 | Final Rejection | 72d | Pending | Apr 26, 2022 |
| 17769642 | COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING ANTIBODIES | Yale University | PATTERSON, SARAH COOPER | 1675 | §112 | Non-Final OA | 11d overdue | Pending | Apr 15, 2022 |
| 17769524 | METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN | Salk Institute For Biological Studies | KIM, TAEYOON | 1631 | §102§103 | Final Rejection | 147d overdue | Pending | Apr 15, 2022 |
| 17762931 | METHOD FOR ISOLATING EXTRACELLULAR VESICLES | Imperial College Innovations Limited | ZINGARELLI, SANDRA | 1653 | §103§112 | Non-Final OA | 34d | Pending | Mar 23, 2022 |
| 17694312 | TOPICAL DRUG DELIVERY DEVICES AND METHODS OF USE | Mjs Solutions, LLC | GHALI, ISIS A D | 1611 | §103§112Other | Final Rejection | 3d overdue | Pending | Mar 14, 2022 |
| 17640756 | COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES | Pontificia Universidad Javeriana | GALSTER, SAMUEL LEONARD | 1693 | §102§103§112 | Non-Final OA | 23d | Pending | Mar 04, 2022 |
| 17677676 | TOPICAL NEUROSTEROID FORMULATIONS | Arizona Board of Regents | STEINKE, SEAN JAMES | 1619 | §103§112DP | Final Rejection | — | Pending | Feb 22, 2022 |
| 17635119 | ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | LUNDE, GRACE HENRY | 1641 | §103§112DP | Non-Final OA | 184d overdue | Pending | Feb 14, 2022 |
| 17635111 | CHIMERIC ANTIGEN RECEPTORS FOR TREATING MYELOID MALIGNANCIES | Regents Of The University Of Minnesota | BERHANE, SELAM | 1675 | §103§112Other | Non-Final OA | 39d | Pending | Feb 14, 2022 |
| 17669059 | THREE-DIMENSIONAL POROUS HYBRID SCAFFOLD AND MANUFACTURE THEREOF | Nanyang Technological University | MARTIN, PAUL C | 1653 | §103§112 | Non-Final OA | 78d | Pending | Feb 10, 2022 |
| 17584547 | CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATORY DOMAINS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | SINGH, ANOOP KUMAR | 1632 | §103§112 | Final Rejection | 59d overdue | Pending | Jan 26, 2022 |
| 17583549 | Composition for and Method of Improving Tissue Performance | Ohio State Innovation Foundation | REYNOLDS, FRED H | 1658 | §102§103§112Other | Non-Final OA | 72d overdue | Pending | Jan 25, 2022 |
| 17626954 | R-Fe-B SINTERED MAGNET AND GRAIN BOUNDARY DIFFUSION TREATMENT METHOD THEREOF | Golden Dragon Rare-Earth Innovation Technology (Xiamen) Co., Ltd. | POLLOCK, AUSTIN M | 1738 | §103 | Non-Final OA | 54d | Pending | Jan 13, 2022 |
| 17625665 | COMPOSITIONS AND METHODS FOR CLEARING TISSUE | The University of Hong Kong | BARRON, SEAN C | 1653 | §103 | Non-Final OA | 11d overdue | Pending | Jan 07, 2022 |
| 17622048 | NEURODEGENERATIVE DISEASE THERAPIES UTILIZING THE SKIN-BRAIN AXIS | Ohio State Innovation Foundation | HUDSON, AMY ROSE | 1636 | §102§103§112 | Non-Final OA | 29d | Pending | Dec 22, 2021 |
| 17557920 | ZERO-VALENT METAL AND BLACK CARBON FRAMEWORK AND METHOD OF USING SAME | MuniRem Environmental, LLC | MAYES, MELVIN C | 1759 | §103§112 | Non-Final OA | 28d overdue | Pending | Dec 21, 2021 |
| 17619116 | DNA METHYLATION BIOMARKERS FOR CANCER DIAGNOSING AND TREATMENT | Arizona Board of Regents | GIAMMONA, FRANCESCA FILIPPA | 1681 | §101§102§103§112DP | Final Rejection | — | Pending | Dec 14, 2021 |
| 17614936 | THERAPEUTIC T-CELLS WITH MODIFIED EXPRESSION OF T-BET, EOMES, AND c-MYB TRANSCRIPTION FACTORS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | CUNNINGCHEN, KATHLEEN MARY | 1646 | §103 | Non-Final OA | — | Pending | Nov 29, 2021 |
| 17296115 | DNA REFERENCE STANDARD AND USE THEREOF | Guangzhou Igene Biotechnology Co., Ltd. | GOLDBERG, JEANINE ANNE | 1682 | §102§103§112 | Final Rejection | 28d overdue | Pending | Oct 29, 2021 |
| 17600692 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | Fusion Pharmaceuticals Inc. | VAJDA, KRISTIN ANN | 1622 | §112 | Final Rejection | — | Pending | Oct 01, 2021 |
| 17600922 | CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING | VERSITECH LIMITED | MARTINEZ, TARA L | 1654 | §102§103 | Final Rejection | 70d | Pending | Oct 01, 2021 |
| 17434909 | REACTIVE ELECTROCHEMICAL MEMBRANE SYSTEM AND METHODS OF MAKING AND USING | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | JEBUTU, MOFOLUWASO SIMILOLUWA | 1795 | §102§103 | Final Rejection | — | Pending | Aug 30, 2021 |
| 17284284 | EXTRACELLULAR VESICLES FOR TARGETED THERAPIES AGAINST MYELOID-DERIVED SUPPRESSOR CELLS | Ohio State Innovation Foundation | GUSTILO, ESTELLA M | 1646 | §112 | Final Rejection | — | Pending | Apr 09, 2021 |
| 17281411 | TLR9-TARGETED THERAPEUTICS | Fulgent Pharma LLC | TRAN, CHRISTINA L | 1637 | §112 | Non-Final OA | 19d overdue | Pending | Mar 30, 2021 |
| 17278189 | IMPROVED HIGH-THROUGHPUT COMBINATORIAL GENETIC MODIFICATION SYSTEM AND OPTIMIZED CAS9 ENZYME VARIANTS | The University of Hong Kong | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103§112 | Final Rejection | 16d overdue | Pending | Mar 19, 2021 |
| 17269968 | TREATMENT OF FLAVIVIRUS INFECTIONS IN HUMANS USING MUS MUSCULUS RESISTANT 2'-5' OLIGOADENYLATE SYNTHETASE 1B | Georgia Tech Research Corporation | DUNSTON, JENNIFER ANN | 1637 | §103§112 | Non-Final OA | 53d overdue | Pending | Feb 19, 2021 |
| 17265751 | ORAL FORMULATIONS WITH INCREASED UPTAKE | Brown University | MITCHELL, EDWIN COLEMAN | 1619 | §103 | Non-Final OA | — | Pending | Feb 03, 2021 |
| 17265756 | COMPOSITIONS AND METHODS FOR DETECTION AND IMAGING OF AMYLOID FIBRILS, AMYLOID PLAQUES, RNA, AND NUCLEOLI | The University of Hong Kong | NGUYEN, NAM P | 1678 | §102§103§112DP | Final Rejection | 43d overdue | Pending | Feb 03, 2021 |
| 17264673 | A JOINT | Ip2Ipo Innovations Limited | SHARPLESS, CHRISTEN ALICIA | 3795 | §102§103 | Non-Final OA | — | Pending | Jan 29, 2021 |
| 17059965 | MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF | Koninklijke Nederlandse Akademie Van Wetenschappen | GOUGH, TIFFANY MAUREEN | 1651 | §112 | Final Rejection | — | Pending | Nov 30, 2020 |
| 16768319 | TRANSGENIC RICE PLANTS OVEREXPRESSING ACYL-COA-BINDING PROTEIN2 SHOW ENHANCED GRAIN SIZE | The University of Hong Kong | BOGGS, RUSSELL T | 1663 | §103 | Final Rejection | 4d overdue | Pending | May 29, 2020 |
| 16619433 | RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | CRAIGO, BAHAR ALAWI | 1699 | §112Other | Non-Final OA | 5d | Pending | Dec 04, 2019 |
| 16598833 | COMPOSITION FOR AND METHOD OF FACILITATING CORNEAL TISSUE REPAIR | Ohio State Innovation Foundation | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Non-Final OA | — | Pending | Oct 10, 2019 |
| 15661272 | ENZYMATIC PRE-TREATMENT OF MARKET PULP TO IMPROVE FIBER DRAINAGE AND PHYSICAL PROPERTIES | Exzymatic Deinking Technologies, LLC | CALANDRA, ANTHONY J | 1748 | §103§112 | Final Rejection | 4d overdue | Pending | Jul 27, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial